Financial Comparison: Sycamore Entertainment Group (OTCMKTS:SEGI) and Forte Biosciences (NASDAQ:FBRX)

Forte Biosciences (NASDAQ:FBRX) and Sycamore Entertainment Group (OTCMKTS:SEGI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, institutional ownership, dividends and earnings.

Profitability

This table compares Forte Biosciences and Sycamore Entertainment Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Forte Biosciences	N/A	-117.85%	-98.67%
Sycamore Entertainment Group	N/A	N/A	N/A

Institutional and Insider Ownership

77.6% of Forte Biosciences shares are owned by institutional investors. 9.6% of Forte Biosciences shares are owned by insiders. Comparatively, 75.5% of Sycamore Entertainment Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Volatility and Risk

Forte Biosciences has a beta of 0.04, indicating that its stock price is 96% less volatile than the S&P 500. Comparatively, Sycamore Entertainment Group has a beta of 49.22, indicating that its stock price is 4,822% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Forte Biosciences and Sycamore Entertainment Group, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Forte Biosciences	0	0	3	0	3.00
Sycamore Entertainment Group	0	0	0	0	0.00

Forte Biosciences presently has a consensus target price of $3.25, indicating a potential downside of 32.29%. Given Forte Biosciences’ stronger consensus rating and higher probable upside, research analysts plainly believe Forte Biosciences is more favorable than Sycamore Entertainment Group.

Earnings & Valuation

This table compares Forte Biosciences and Sycamore Entertainment Group”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Forte Biosciences	N/A	N/A	-$31.48 million	($18.25)	-0.26
Sycamore Entertainment Group	N/A	N/A	N/A	N/A	N/A

About Forte Biosciences

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

About Sycamore Entertainment Group

Sycamore Entertainment Group, Inc., a diversified entertainment company, which specializes in the acquisition, marketing, and worldwide distribution of feature-length motion pictures. The company is based in Seattle, Washington.